Website intended for a NZ health professional readership
We are on our summer break and the editorial office is closed until 13 January. In the meantime, please enjoy our Summer Hiatus series, in which our journalists curate an eclectic mix from our news and clinical archives throughout the year, The Conversation and other publications we share content with. Please note the comment function has been turned off while we are away. Happy reading!
This article was first published online on 19 June.
From Barbara: Budget is always a big deal here in the newsroom. We are eternally optimistic, but likewise eternally disappointed. It’s been a few years since we could write a cracker yarn about a significant increase in primary care funding. This year was no different. Our regular policy puzzler (and Auckland university professor of health systems) Tim Tenbensel explains the problem at hand when it comes to attracting Budget money to primary care
Pharmacist prescribers Linda Bryant and Leanne Te Karu discuss positive polypharmacy for heart failure. Current evidence shows the intensive implementation of four medications offers the greatest benefit to most patients with heart failure, with significant reductions in cardiovascular mortality, heart failure hospitalisations and all-cause mortality
